Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$616M |
| 2 |
Netflix
NFLX
|
+$481M |
| 3 |
Micron Technology
MU
|
+$416M |
| 4 |
Tesla
TSLA
|
+$416M |
| 5 |
Procter & Gamble
PG
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$885M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$660M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$463M |
| 4 |
Applovin
APP
|
+$430M |
| 5 |
Meta Platforms (Facebook)
META
|
+$354M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.84% |
| 2 | Healthcare | 15.77% |
| 3 | Consumer Discretionary | 13.88% |
| 4 | Industrials | 9.94% |
| 5 | Financials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Caribou Biosciences
CRBU
$156M
| $2.61M | ﹤0.01% |
1,639,857
+859,436
| +110% | +$1.8M |
|
|
FBLA
1702
FB Bancorp
FBLA
$255M
| $2.61M | ﹤0.01% |
202,900
+159,700
| +370% | +$1.98M |
|
1703
Entrada Therapeutics
TRDA
$281M
| $2.6M | ﹤0.01% |
252,635
-341,665
| -57% | -$2.88M |
|
1704
Neumora Therapeutics
NMRA
$296M
| $2.59M | ﹤0.01% |
1,445,902
+281,926
| +24% | +$617K |
|
1705
ZTO Express
ZTO
$18.2B
| $2.58M | ﹤0.01% |
123,700
-196,300
| -61% | -$3.89M |
|
1706
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.55B
| $2.58M | ﹤0.01% |
40,319
+28,319
| +236% | +$1.83M |
|
1707
Taylor Devices
TAYD
$173M
| $2.58M | ﹤0.01% |
44,162
+700
| +2% | +$33.9K |
|
1708
Envela
ELA
$569M
| $2.57M | ﹤0.01% |
192,104
-6,600
| -3% | -$68.9K |
|
1709
The Oncology Institute
TOI
$513M
| $2.57M | ﹤0.01% |
721,900
-28,600
| -4% | -$106K |
|
1710
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.18B
| $2.57M | ﹤0.01% |
+193,858
| New | +$2.62M |
|
1711
OceanFirst Financial
OCFC
$1.72B
| $2.57M | ﹤0.01% |
143,043
-21,300
| -13% | -$398K |
|
1712
Virtus Investment Partners
VRTS
$1.11B
| $2.57M | ﹤0.01% |
15,729
+13,200
| +522% | +$2.23M |
|
1713
NBT Bancorp
NBTB
$2.8B
| $2.56M | ﹤0.01% |
61,773
-7,600
| -11% | -$316K |
|
1714
West Fraser Timber
WFG
$5.48B
| $2.56M | ﹤0.01% |
41,900
+14,000
| +50% | +$876K |
|
|
DCBO
1715
Docebo
DCBO
$523M
| $2.55M | ﹤0.01% |
115,031
-14,102
| -11% | -$337K |
|
|
RPTX
1716
DELISTED
Repare Therapeutics
RPTX
| $2.55M | ﹤0.01% |
981,360
+257,200
| +36% | +$518K |
|
1717
Mistras Group
MG
$507M
| $2.55M | ﹤0.01% |
201,600
+20,800
| +12% | +$235K |
|
1718
Humana
HUM
$43.5B
| $2.55M | ﹤0.01% |
9,953
-426,847
| -98% | -$112M |
|
1719
Invivyd
IVVD
$169M
| $2.54M | ﹤0.01% |
+1,026,620
| New | +$2.14M |
|
1720
Vertical Aerospace
EVTL
$176M
| $2.53M | ﹤0.01% |
474,400
+27,200
| +6% | +$138K |
|
|
CURB
1721
Curbline Properties
CURB
$3.46B
| $2.53M | ﹤0.01% |
+108,817
| New | +$2.54M |
|
|
ABX
1722
Abacus Global Management
ABX
$1.04B
| $2.52M | ﹤0.01% |
295,000
-166,900
| -36% | -$1.1M |
|
1723
CION Investment
CION
$315M
| $2.52M | ﹤0.01% |
260,800
-46,700
| -15% | -$450K |
|
|
MITT
1724
TPG Mortgage Investment Trust
MITT
$227M
| $2.52M | ﹤0.01% |
295,741
-50,600
| -15% | -$397K |
|
1725
Teradata
TDC
$3.24B
| $2.52M | ﹤0.01% |
82,632
-705,963
| -90% | -$18.5M |
|
Similar funds
Renaissance Technologies's Q4 2025 Portfolio in Review
As of Q4 2025, Renaissance Technologies held 3,923 positions worth $64.5B, down 15% from $75.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $10.1B in Q4 2025, closing 737 positions and reducing 1,682 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $354M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in ServiceNow worth $204M.
- Renaissance Technologies's largest Q4 2025 buy was ServiceNow: 1,331,977 shares worth $204M.
- Renaissance Technologies added most to Costco in Q4 2025, an estimated $616M increase.
- Renaissance Technologies's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $885M.
- Renaissance Technologies fully exited Meta Platforms (Facebook) in Q4 2025, selling an estimated $354M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.5B portfolio in Q4 2025.
- Renaissance Technologies opened 466 new positions and closed 737 in Q4 2025.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $64.5B.
Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.